Medicare Enrolled
Dr. Steven Herzog, M.D.
Neurology · Dallas, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Herzog from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Herzog?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Herzog
Dr. Steven Herzog is a neurology specialist in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Herzog performed 211,464 Medicare services across 1,825 unique beneficiaries.
Between the years covered by Open Payments, Dr. Herzog received a total of $458,609 from 64 pharmaceutical and/or device companies across 1162 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Herzog is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in TX
$458,609 industry payments
Medicare Practice Summary
Medicare Utilization ↗211,464
Medicare services
Top 0% in TX for neurology
1,825
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~10,573 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
157,610 | $5 | $20 |
| Injection, eptinezumab-jjmr, 1 mg | 35,000 | $13 | $65 |
| MRI contrast dye injection (gadoterate) Administration of gadoterate meglumine, a contrast agent, in a 0.1 ml dose. |
15,089 | $0 | $1 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
940 | $117 | $435 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
740 | $0 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
464 | $90 | $331 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
404 | $0 | $5 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
306 | $10 | $80 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
150 | $51 | $215 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
128 | $68 | $225 |
| Facial nerve injection with anesthetic and/or steroid An injection of an anesthetic agent and/or steroid into the facial nerve. This procedure delivers medication directly to the nerve. |
75 | $122 | $582 |
| Anti-nausea injection (ondansetron/Zofran) | 63 | $0 | $5 |
| MRI of brain with and without contrast An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures. |
58 | $171 | $1,530 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
53 | $41 | $447 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 53 | $60 | $351 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
48 | $24 | $195 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
47 | $116 | $500 |
| New patient office visit, complex (60-74 min) | 45 | $174 | $630 |
| Trigeminal nerve block injection An injection of an anesthetic agent into the trigeminal nerve bundle to numb the area. |
38 | $104 | $379 |
| MRI of head blood vessels without contrast An MRI scan that creates detailed images of the blood vessels in the head without using contrast dye. |
35 | $77 | $1,225 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
35 | $23 | $95 |
| MRI of neck blood vessels with and without contrast This procedure uses magnetic resonance imaging to create detailed pictures of the blood vessels in the neck. Images are taken both before and after the administration of a contrast dye to enhance visibility. |
28 | $217 | $1,930 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
26 | $135 | $440 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $45 | $135 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $78 | $330 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
99.6% medium
0.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$458,609
Total received (2018-2024)
Avg $65,516/year across 7 years
Top 1% in TX for neurology
64
Companies
1,162
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$427,882 (93.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$21,192 (4.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,534 (2.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$70,476
2023
$36,935
2022
$73,468
2021
$128,417
2020
$95,741
2019
$32,302
2018
$21,270
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$160,172
Allergan, Inc.
$104,743
AbbVie Inc.
$97,477
Allergan Inc.
$45,852
Biohaven Pharmaceuticals, Inc.
$16,417
Biohaven Pharmaceutical Holding Company Ltd.
$14,912
Promius Pharma LLC
$4,782
Lundbeck LLC
$3,457
Teva Pharmaceuticals USA, Inc.
$2,022
Sunovion Pharmaceuticals Inc.
$798
Genentech USA, Inc.
$787
Lilly USA, LLC
$719
Amgen Inc.
$596
Novartis Pharmaceuticals Corporation
$572
UCB, Inc.
$410
PFIZER INC.
$399
Supernus Pharmaceuticals, Inc.
$358
ARGENX US, INC.
$327
Biogen, Inc.
$284
Alexion Pharmaceuticals, Inc.
$232
Merz Pharmaceuticals, LLC
$225
Amneal Pharmaceuticals LLC
$221
GENZYME CORPORATION
$179
Upsher-Smith Laboratories LLC
$176
Janssen Pharmaceuticals, Inc
$166
UPSHER-SMITH LABORATORIES LLC
$163
Takeda Pharmaceuticals U.S.A., Inc.
$152
SK Life Science, Inc.
$143
Mitsubishi Tanabe Pharma America, Inc.
$136
Grifols USA, LLC
$135
Acorda Therapeutics, Inc
$132
Avanir Pharmaceuticals, Inc.
$129
Eisai Inc.
$127
MERZ NORTH AMERICA, INC.
$103
Neurocrine Biosciences, Inc.
$97
CSL Behring
$92
Alnylam Pharmaceuticals Inc.
$91
EMD Serono, Inc.
$83
Siemens Medical Solutions USA, Inc.
$64
Horizon Therapeutics plc
$59
Ipsen Biopharmaceuticals, Inc
$56
Neurelis, Inc.
$46
Kyowa Kirin, Inc.
$45
TG Therapeutics, Inc.
$40
ACADIA Pharmaceuticals Inc
$40
Assertio Therapeutics, Inc.
$39
Adamas Pharmaceuticals, Inc.
$31
TG THERAPEUTICS, INC.
$29
Mallinckrodt Enterprises LLC
$28
HOSPIRA, INC.
$26
Bayer HealthCare Pharmaceuticals Inc.
$25
Harmony Biosciences Llc
$24
Octapharma USA, Inc.
$21
Boston Scientific Corporation
$19
Scilex Pharmaceuticals Inc.
$18
Philips Electronics North America Corporation
$18
Medtronic USA, Inc.
$17
Almatica Pharma LLC
$15
BOSTON SCIENTIFIC CORPORATION
$15
GE HEALTHCARE
$15
BANNER LIFE SCIENCES, LLC
$15
Greenwich Biosciences, Inc.
$14
Avion Pharmaceuticals
$13
Bausch Health US, LLC
$11
Top 3 companies account for 79.0% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · Aimovig · BAFIERTAM · BOTOX · BOTOX - NEUROLOGY · BOTOX COSMETIC · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · CAMBIA · COMIRNATY · COPAXONE · DUOPA · DYSPORT · Dhivy · Dysport · EMGALITY · Enspryng · Epidiolex · FABRY-DISEASE · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Gralise · HYQVIA · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KYNMOBI · LEADPOINT · LUMIZYME · LYRICA · Leqembi · MIGRANAL · Mavenclad · NAPRELAN · NEXVIAZYME · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · ONZETRA Xsail · OXTELLAR XR · Ocrevus · PANZYGA · PAXLOVID · QUDEXY · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · REXULTI · RYTARY · Radicava · Rebif · SOLIRIS · Soliris · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VERSANT kPCR Molecular System SP · VRAYLAR · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · WAKIX · XEOMIN · Xeomin · ZEMBRACE SYMTOUCH · ZOMIG · ZTLido · Zembrace · Zipsor · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for neurology in TX.
Equivalent to $217 per 100 Medicare services performed
Geographic Context
Neurologists within 10 mi
241
Per 100K population
9.3
County median income
$74,149
Nearest hospital
BAYLOR SCOTT AND WHITE MEDICAL CENTER UPTOWN
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Herzog is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), with speaking/promotional industry engagement in the top 1% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Herzog experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Herzog performed 157,610 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Herzog receive payments from pharmaceutical companies?
Yes. Dr. Herzog received a total of $458,609 from 64 companies across 1,162 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Herzog's costs compare to other neurologists in Dallas?
Dr. Herzog's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Herzog) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Dallas
Browse neurologists in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in TX
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in TX
Which TX neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology